Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06360718 · ClinicalTrials.gov registry record · NA

Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress.

A NA study of Leukemia, sponsored by Children's Hospital Los Angeles.

Recruiting
Registry status
NA
Development phase
140
Enrollment target
1
Study location

NCT06360718: Recruiting NA study of Leukemia, sponsored by Children's Hospital Los Angeles.

NCT06360718 is a NA study of Leukemia that is actively recruiting participants, run by Children's Hospital Los Angeles. The registered enrollment target is 140 participants, below the 486-participant average among 233 other Leukemia trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06360718, a NA study of Leukemia, is actively recruiting participants, sponsored by Children's Hospital Los Angeles.

RECRUITING
Registry status
NA
Development phase
140 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to measure the effects of using a storybook versus standard child life intervention with parents of children newly diagnosed with leukemia on parental stress. The main questions it aims to answer are: * What effect will the storybook have on parent/legal guardian stress at three timepoints: baseline, discharge, and follow up? * Will this storybook impact parent/legal guardian comfort levels and improve their child's understanding? Participants will be asked to complete surveys at three timepoints, prior to and following child life intervention and about 3.5 months later. During child life interventions, participants will receive resources and support to explain leukemia to their school aged, 3-16-year-old, child (patient or sibling). Researchers will compare Intervention and Control Groups to see if parental stress is lower in those who received the storybook in addition to the standard child life intervention versus the standard child life intervention alone.

Primary Outcome

All participating parents/legal guardians will be given the Parenting Stress Index -4 Short Form \[PSI™-4-SF\] at baseline (before child life intervention), discharge (about 1 week following the child life intervention for extended admissions), and about 3.5 months after the initial survey. The PSI™-4-SF form is a 36-item scale, available in English and Spanish. The form is broken into two domains (child and parent). The questions in the Parent Domain look at identifying sources of stress.

Conditions Studied

Interventions

  • BEHAVIORAL "Who is Luke Eemia?" Storybook

Study Locations (1)

California

  • Children's Hospital Los Angeles - Los Angeles

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2024-02-03
Est. Completion 2026-07-01
Phase NA
Children's Hospital Los Angeles

119 total trials

What NCT06360718 shows while recruiting

NCT06360718 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 486-participant average among 233 other Leukemia trials with a reported enrollment target (71% lower).

The record links to 1 condition, with Leukemia appearing as the primary indexed condition, and to 1 intervention - of which "Who is Luke Eemia?" Storybook is the first listed.

NCT06360718 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06360718 about?

NCT06360718 is a clinical study titled "Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress.". The goal of this clinical trial is to measure the effects of using a storybook versus standard child life intervention with parents of children newly diagnosed with leukemia on parental stress. The main questions it aims to answer are: * What effect will the storybook have on parent/legal guardian...

What is the current status of trial NCT06360718?

This trial is currently recruiting. It is a NA study. The enrollment target is 140 participants. The study started on 2024-02-03. Estimated completion is 2026-07-01.

What conditions does trial NCT06360718 study?

This clinical trial studies the following conditions: Leukemia.

What interventions are being tested in trial NCT06360718?

The interventions under investigation include: "Who is Luke Eemia?" Storybook (BEHAVIORAL).

Who is sponsoring clinical trial NCT06360718?

This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06360718 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Leukemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06360718's enrollment target sits among peer trials

140 48th of 233 higher than 185 of 233 other Leukemia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Leukemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01419561 · 140 participants · Phase 2

    Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)

  • NCT01624805 · 140 participants · Phase 2

    Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome

  • NCT02369770 · 140 participants · NA

    Sensory-Motor Rehabilitation Post Stroke

  • NCT02455193 · 140 participants · NA

    Neuronal Effects of Exercise in Schizophrenia

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06360718, the US trial registry maintained by the National Library of Medicine. NCT06360718 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.